Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/32994
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCorrea, Joao A.
dc.contributor.authorAbreu, Luiz Carlos de
dc.contributor.authorPires, Adilson C.
dc.contributor.authorBreda, João Roberto [UNIFESP]
dc.contributor.authorYamazaki, Yumiko R.
dc.contributor.authorFioretti, Alexandre C.
dc.contributor.authorValenti, Vitor Engrácia [UNIFESP]
dc.contributor.authorVanderlei, Luiz Carlos M.
dc.contributor.authorMacedo Junior, Hugo
dc.contributor.authorColombari, Eduardo [UNIFESP]
dc.contributor.authorMiranda Junior, Fausto [UNIFESP]
dc.date.accessioned2016-01-24T14:05:34Z-
dc.date.available2016-01-24T14:05:34Z-
dc.date.issued2010-10-18
dc.identifierhttp://dx.doi.org/10.1186/1471-2482-10-28
dc.identifier.citationBmc Surgery. London: Biomed Central Ltd, v. 10, 7 p., 2010.
dc.identifier.issn1471-2482
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/32994-
dc.description.abstractBackground: An upper limb arteriovenous (AV) fistula is the access of choice for haemodialysis (HD). There have been few reports of saphenofemoral AV fistulas (SFAVF) over the last 10-20 years because of previous suggestions of poor patencies and needling difficulties. Here, we describe our clinical experience with SFAVF.Methods: SFAVFs were evaluated using the following variables: immediate results, early and late complications, intraoperative and postoperative complications (up to day 30), efficiency of the fistula after the onset of needling and complications associated to its use.Results: Fifty-six SFAVF fistulas were created in 48 patients. Eight patients had two fistulas: 8 patent (16%), 10 transplanted (20%), 12 deaths (24%), 1 low flow (2%) and 20 thrombosis (39%) (first two months of preparation). One patient had severe hypotension during surgery, which caused thrombosis of the fistula, which was successfully thrombectomised, four thrombosed fistulae were successfully thrombectomised and revised on the first postoperative day. After 59 months of follow-up, primary patency was 44%.Conclusion: SFAVF is an adequate alternative for patients without the possibility for other access in the upper limbs, allowing efficient dialysis with good long-term patency with a low complication rate.en
dc.description.sponsorshipNucleo de Estudos, Pesquisas e Assessoria a Saude da Faculdade de Medicina do ABC (NEPAS-FMABC)
dc.format.extent7
dc.language.isoeng
dc.publisherBiomed Central Ltd
dc.relation.ispartofBmc Surgery
dc.rightsAcesso aberto
dc.titleSaphenofemoral arteriovenous fistula as hemodialysis accessen
dc.typeArtigo
dc.contributor.institutionFac Med ABC
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionUniv Estadual Paulista UNESP
dc.description.affiliationFac Med ABC, Dept Cirugia, Santo Andre, SP, Brazil
dc.description.affiliationFac Med ABC, Dept Morfol & Fisiol, Lab Escrita Cient, Santo Andre, SP, Brazil
dc.description.affiliationUniversidade Federal de São Paulo UNIFESP, Dept Med, Disciplina Cardiol, São Paulo, Brazil
dc.description.affiliationUniv Estadual Paulista UNESP, Dept Fisioterapia, Presidente Prudente, SP, Brazil
dc.description.affiliationUniversidade Federal de São Paulo UNIFESP, Disciplina Cirurgia Cardiovasc, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo UNIFESP, Dept Med, Disciplina Cardiol, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo UNIFESP, Disciplina Cirurgia Cardiovasc, São Paulo, Brazil
dc.identifier.fileWOS000296432400001.pdf
dc.identifier.doi10.1186/1471-2482-10-28
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000296432400001
Appears in Collections:Artigo

Files in This Item:
File Description SizeFormat 
WOS000296432400001.pdf834.86 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.